Heel Fat Pad Atrophy: When Your Natural Shock Absorber Wears Out

Medically reviewed by Dr. Tom Biernacki, DPM — Board-Certified Podiatric Surgeon — Balance Foot & Ankle, Howell & Bloomfield Hills, MI. Last updated April 2026.

▶ Watch

Understanding the Heel Fat Pad

The heel fat pad is a highly specialized structure composed of adipose tissue organized within fibrous septa (chambers) arranged in a honeycomb pattern beneath the calcaneal tuberosity. This unique architecture allows the fat pad to compress under load and rebound to its original thickness, functioning as the body’s natural shock absorber for the approximately 110 tons of cumulative force the heel absorbs during a single day of walking.

A healthy heel fat pad measures 15-25mm in thickness on ultrasound and contains closed compartments of fat cells held in place by strong elastic fibrous walls. The septa maintain fat pad integrity by preventing lateral displacement of adipose tissue during weight-bearing, ensuring consistent cushioning properties throughout the gait cycle.

Unlike subcutaneous fat elsewhere in the body, heel pad fat has a dual blood supply and dense nerve network that make it exquisitely sensitive to pressure changes. When the fat pad thins below critical thickness (less than 12mm), the calcaneal tuberosity impacts the ground surface with insufficient cushioning, producing the characteristic deep heel pain of fat pad atrophy.

Causes of Heel Fat Pad Thinning

Age-related degeneration is the most common cause of heel fat pad atrophy. After age 40, the elastic collagen fibers within the septal walls gradually lose elasticity, and the adipose tissue volume decreases. By age 70, average heel pad thickness has decreased by approximately 30% compared to age 30, though the rate of atrophy varies significantly between individuals.

Repetitive high-impact activities accelerate fat pad deterioration by damaging the septal architecture faster than the body can repair it. Long-distance runners, basketball players, and individuals who work on hard concrete floors accumulate microtrauma that progressively weakens the honeycomb structure and allows fat displacement.

Corticosteroid injections into the plantar heel — commonly administered for plantar fasciitis — can cause iatrogenic fat pad atrophy. Corticosteroids suppress local adipocyte function and weaken the fibrous septa, potentially converting a treatable plantar fasciitis condition into irreversible fat pad atrophy. This is why injection frequency and technique matter significantly.

Systemic conditions including diabetes, peripheral neuropathy, rheumatoid arthritis, and lupus can accelerate heel pad degeneration through impaired tissue metabolism, inflammatory damage to septal structures, and altered weight-bearing patterns. Patients with these conditions develop symptomatic fat pad atrophy at earlier ages than the general population.

Symptoms and Diagnosis

Heel fat pad atrophy produces a deep, aching pain directly beneath the center of the heel that is distinctly different from the medial heel pain of plantar fasciitis. Patients describe the sensation as walking on a stone or on bare bone, and the pain worsens on hard surfaces, with thin-soled shoes, and after prolonged standing — but unlike plantar fasciitis, it does not typically improve with walking after initial morning steps.

The distinguishing clinical feature is that fat pad pain is worst with the first steps of the morning AND remains painful throughout activity, while plantar fasciitis classically improves after the first 10-15 minutes of walking. Fat pad atrophy pain is also provoked by direct palpation of the central heel rather than the medial tubercle where the plantar fascia attaches.

Diagnostic ultrasound provides definitive measurement of heel fat pad thickness. Dr. Biernacki uses in-office ultrasound to measure fat pad thickness under both loaded and unloaded conditions, comparing measurements to age-adjusted norms. Pad thickness below 12mm is diagnostic of clinically significant atrophy, while measurements between 12-15mm represent borderline atrophy that warrants monitoring.

MRI is occasionally ordered when diagnostic uncertainty exists or when concomitant pathology such as plantar fasciitis, calcaneal stress fracture, or Baxter’s nerve entrapment must be ruled out. MRI provides detailed visualization of fat pad internal architecture and can identify septal disruption patterns that ultrasound cannot resolve.

Conservative Treatment Approaches

Custom heel cushioning orthotics with deep heel cups and viscoelastic padding represent the first-line treatment for heel fat pad atrophy. Unlike standard arch-support orthotics designed for plantar fasciitis, fat pad atrophy orthotics prioritize heel-specific cushioning with soft durometer materials that mimic the shock absorption properties of healthy fat pad tissue.

Heel cups and gel cushion inserts provide immediate symptomatic relief by adding external cushioning material beneath the atrophied fat pad. Silicone gel heel cups that wrap around the heel perimeter are particularly effective because they centralize the remaining fat pad tissue beneath the calcaneal tuberosity, concentrating available cushioning where it is needed most.

Footwear modification is essential. Patients with fat pad atrophy should avoid completely flat shoes, minimalist footwear, and any shoe with a thin, hard sole. Athletic shoes with maximum heel cushioning, rocker-bottom soled shoes, and shoes with built-in shock-absorbing technology significantly reduce symptom severity.

Activity modification including avoidance of high-impact exercise on hard surfaces, use of cushioned exercise mats for standing activities, and replacement of running with lower-impact alternatives such as cycling or swimming reduces the cumulative heel impact that exacerbates symptoms.

Fat Pad Augmentation and Advanced Treatments

Autologous fat grafting involves harvesting fat tissue from the patient’s abdomen or thigh through liposuction and injecting it beneath the atrophied heel pad. This procedure restores biological cushioning with the patient’s own tissue and has shown promising results in clinical studies, with 60-70% fat graft survival at one year follow-up.

Dermal filler injection with cross-linked hyaluronic acid or polyacrylamide gel provides synthetic fat pad augmentation through an in-office procedure. Studies published in Foot and Ankle International (2024) demonstrated significant pain reduction and improved functional scores lasting 12-18 months per treatment session.

Platelet-rich plasma (PRP) injection into the fat pad aims to improve tissue quality and stimulate adipocyte regeneration within the remaining fat pad structure. While evidence is still emerging, early results suggest PRP may slow progressive atrophy and improve the elastic properties of the septal framework.

Custom silicone heel implants are a surgical option for severe fat pad atrophy unresponsive to all conservative and injectable treatments. These medical-grade silicone cushions are surgically placed beneath the calcaneus through a small heel incision and provide permanent shock absorption. This procedure is reserved for the most severe cases due to surgical risks.

Preventing Further Fat Pad Deterioration

Protecting the remaining fat pad from further damage requires consistent use of cushioned footwear and orthotic devices during all weight-bearing activities. Even brief periods of walking barefoot or in unsupportive shoes on hard surfaces accelerates atrophy progression. Patients should keep supportive slippers beside the bed to avoid barefoot walking immediately upon rising.

Limiting corticosteroid injections to the heel area prevents iatrogenic fat pad damage. If corticosteroid injection is needed for concurrent plantar fasciitis, ultrasound guidance ensures precise placement within the fascial tissue rather than the fat pad, and injection frequency should not exceed 2-3 times per year.

Weight management reduces per-step heel impact forces proportionally. Each pound of body weight translates to approximately 3 pounds of force through the heel during walking. Even modest weight loss of 10-15 pounds can meaningfully reduce heel pain symptoms in patients with marginal fat pad thickness.

Dr. Tom Biernacki, DPM

Affiliate Disclosure: This page contains affiliate links to products we recommend. If you purchase through these links, Balance Foot & Ankle may earn a small commission at no additional cost to you. We only recommend products we use with our patients.

Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.